Data Collection during the COVID-19 Pandemic: Learning from Experience, Resulting in a Bayesian Repertory

Abstract

Background A novel pandemic disease offered the opportunity to create new, disease-specific, symptom rubrics for the homeopathic repertory.

Objective The aim of this study was to discover the relationship between specific symptoms and specific medicines, especially of symptoms occurring frequently in this disease.

Materials and Methods Worldwide collection of data in all possible formats by various parties was coordinated by the Liga Medicorum Homeopathica Internationalis. As the data came in, more symptoms were assessed prospectively. Frequent analysis and feedback by electronic newsletters were used to improve the quality of the data. Likelihood ratios (LRs) of symptoms were calculated. An algorithm for combining symptom LRs was programmed and published in the form of an app. The app was tested against 18 well-described successful cases from Hong Kong.

Results LRs of common symptoms such as ‘Fatigue’ and ‘Headache’ provided better differentiation between medicines than did existing repertory entries, which are based only on the narrow presence or absence of symptoms. A mini-repertory for COVID-19 symptoms was published and supported by a web-based algorithm. With a choice of 20 common symptoms, this algorithm produced the same outcome as a full homeopathic analysis based upon a larger number of symptoms, including some that are traditionally considered more specific to particular medicines.

Conclusion A repertory based on clinical data and LRs can differentiate between homeopathic medicines using a limited number of frequently occurring epidemic symptoms. A Bayesian computer algorithm to combine symptoms can complement a full homeopathic analysis of cases.

Keywords

COVID-19 - repertory - Bayes' theorem - data collection - prognostic factor

Publication History

Received: 11 August 2020

Accepted: 09 September 2020

Article published online:
04 January 2021

• References

• 1 World Health Organization. Coronavirus Disease COVID-2019. Situation Report. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
• 2 Coronavirus Disease 2019 (COVID-19). Symptoms pf Coronavirus. Accessed on June 5, 2020 at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
• 3 Jacobs J. Homeopathic prevention and management of epidemic diseases. Homeopathy 2018; 107: 157-160
• 4 Ielciu I, Mouithys-Mickalad A, Franck T. et al. Flavonoid composition, cellular antioxidant activity and (myelo)peroxidase inhibition of a Bryonia alba L. (Cucurbitaceae) leaves extract. J Pharm Pharmacol 2019; 71: 230-239
• 5 Basu N, Das BC, Tandon S. Interim management of COVID-19 by repurposed homeopathic medicines. Homeopathy 2020; 109: 182-183
• 6 To KLA, Fok YYY. Homeopathic clinical features of 18 patients in COVID-19 outbreaks in Hong Kong. Homeopathy 2020; 109: 146-162
• 7 Federation of Medical Scientific Societies. Code of Conduct for Medical Research. Available at: https://english.ccmo.nl/investigators/legal-framework-for-medical-scientific-research/codes-of-conduct/code-of-conduct-for-medical-research
• 8 Rutten ALB, Stolper CF, Lugten RFG, Barthels RWJM. Statistical analysis of six repertory rubrics after prospective assessment applying Bayes' theorem. Homeopathy 2009; 98: 26-34
• 9 Miglani A, Rutten L, Manchanda RK. Generalisability of prognostic factor research: further analysis of data from the IIPCOS2 study. Homeopathy 2017; 106: 155-159
• 10 Rutten ALB, Stolper CF, Lugten RF, Barthels RW. ‘Cure’ as the gold standard for likelihood ratio assessment: theoretical considerations. Homeopathy 2004; 93: 78-83
• 11 Rutten ALB, Stolper CF. Diagnostic test evaluation by patient-outcome study in homeopathy: balancing of feasibility and validity. J Eval Clin Pract 2009; 15: 1230-1235
• 12 Rutten L, Van Wassenhoven M. Clinical verification of homeopathic symptoms: experience and statistics. In: Bonamin L. ed. Signals and Images. Springe Science + Business Media; 2008: 151-182